Quickly, Simply Diagnose Dry Eye at Lower Cost
ADMiER: Acoustically-Driven Microfluidic Extensional Rheometry
Tags: University of Melbourne, Australia, Healthcare & Lifesciences
ADMiER revolutionizes dry eye diagnosis, reducing chair-time from 18 to 3 minutes. This in-vitro device analyzes a microlitre tear droplet, offering a simple, rapid, and cost-effective solution with 92% patient preference. Addressing a prevalent issue affecting one in five adults, it promises enhanced diagnostics and treatment guidance. With potential to significantly impact ophthalmic practice, ADMiER offers a novel approach for tear film assessment.
IP Type or Form Factor: Patent Granted; Device
TRL: Not specified
Industry or Tech Area: Diagnostics & Screening; Healthcare Provider
![ADMiER: Acoustically-Driven Microfluidic Extensional Rheometry](https://substackcdn.com/image/fetch/w_720,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F460800a1-b91a-4afd-b992-c9e10b03c544_1024x1024.jpeg)
![ADMiER: Acoustically-Driven Microfluidic Extensional Rheometry](https://substackcdn.com/image/fetch/w_720,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F28cd70dc-6d22-46f9-bf41-1ffaa0c0d6ad_432x596.png)